Mendus AB Stock: price and insider trades · Sweden

Mendus AB belongs to the Health Care sector. Filings by its managers are published through Finansinspektionen. 8 insiders have disclosed 19 filings since 18 October 2025.

No insider sold shares on the market over the period. Instead, the filings list 18 purchases totalling €352k, made by 8 insiders. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. At €92k, the purchase published on 19 December 2025 by Erik Manting is the largest of the period. Among those who bought: 5 board members, 2 chief executives and 1 finance chief.

For context, the typical company on the same exchange (median of 890 companies) published 7 filings over the same period, against 19 filings here. Since 2025, the database holds 22 purchases and no sales by insiders of the company.

In all, 13 purchases were made within 30 days of a purchase by another insider of the company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The latest purchase dates back some time: it was published 84 days ago, on 25 July 2026. The median gap between a trade and its publication by Finansinspektionen is 3 days. Under the Market Abuse Regulation, managers have three business days to notify their trades.

In the same sector, recent insider purchases at Anixa Biosciences Inc and Vivos Inc also feature in our signals. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.